225
Views
24
CrossRef citations to date
0
Altmetric
Urology

Long-term follow-up in spinal dysraphism: Outcome of renal function and urinary and faecal continence

, &
Pages 95-100 | Received 05 Dec 2008, Accepted 17 Nov 2009, Published online: 27 Feb 2010

References

  • Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele. J Urol 1999;162:1068–71.
  • Wu HY, Baskin LS, Kogan BA. Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment. J Urol 1997;157:2295–7.
  • Edelstein RA, Bauer SB, Kelly MD, Darbey MM, Peters CA, Atala A, The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 1995;154:1500–4.
  • Dik P, Klijn AJ, van Gool JD, de Jong-de Vos van Steenwijk CC, de Jong TP. Early start to therapy preserves kidney function in spina bifida patients. Eur Urol 2006;49:908–13.
  • Kurzrock EA, Polse S. Renal deterioration in myelodysplastic children: urodynamic evaluation and clinical correlates. J Urol 1998;159:1657–61.
  • Hopps CV, Kropp KA. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup. J Urol 2003;169:305–8.
  • Teichman JM, Scherz HC, Kim KD, Cho DH, Packer MG, Kaplan GW. An alternative approach to myelodysplasia management: aggressive observation and prompt intervention. J Urol 1994;152:807–11.
  • McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981;126:205–9.
  • Sillen U, Hansson E, Hermansson G, Hjalmas K, Jacobsson B, Jodal U. Development of the urodynamic pattern in infants with myelomeningocele. Br J Urol 1996;78:596–601.
  • Tarcan T, Bauer S, Olmedo E, Khoshbin S, Kelly M, Darbey M. Long-term followup of newborns with myelodysplasia and normal urodynamic findings: is followup necessary? J Urol 2001;165:564–7.
  • Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol 1972;107:458–61.
  • Cass AS, Luxenberg M, Gleich P, Johnson CF, Hagen S. Clean intermittent catheterization in the management of the neurogenic bladder in children. J Urol 1984;132:526–8.
  • Mitchell ME, Kulb TB, Backes DJ. Intestinocystoplasty in combination with clean intermittent catheterization in the management of vesical dysfunction. J Urol 1986;136:288–91.
  • Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA. Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg 2001;34:114–20.
  • Olsson I, Dahl M, Mattsson S, Wendelius M, Astrom E, Westbom L. Medical problems in adolescents with myelomeningocele (MMC): an inventory of the Swedish MMC population born during 1986–1989. Acta Paediatr 2007;96:446–9.
  • Almodhen F, Capolicchio JP, Jednak R, El SM. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele. J Urol 2007;178:1479–82.
  • Krogh K, Lie HR, Bilenberg N, Laurberg S. Bowel function in Danish children with myelomeningocele. APMIS 2003;(Suppl 109):81–5.
  • Verhoef M, Lurvink M, Barf HA, Post MW, van Asbeck FW, Gooskens RH, High prevalence of incontinence among young adults with spina bifida: description, prediction and problem perception. Spinal Cord 2005;43:331–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.